Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Colman

Showing results (261-270 of 265) with videos related to

Pageof 27
Sort By:
You have reached the last page of results.This site can display upto 265 results.
Blood|September 1, 1987
Direct evidence for the interaction of the nucleotide affinity analog 5'-p-fluorosulfonylbenzoyl adenosine with a platelet ADP receptorW R Figures, L M Scearce, P DeFeo, et al.
Archives of Biochemistry and Biophysics|April 1, 1988
Distinction between glycoprotein IIIa and the 100-kDa membrane protein (aggregin) mediating ADP-induced platelet activationR W Colman, W R Figures, Q X Wu, et al.
Transactions of the Association of American Physicians|January 1, 1986
Separation of the 100-kDa membrane protein mediating ADP-induced platelet shape change and activation from glycoprotein IIIaR W Colman, W R Figures, Q X Wu, et al.
Bioorganic Chemistry|April 17, 2002
A new nonhydrolyzable reactive cAMP analog, (Sp)-adenosine-3',5'-cyclic-S-(4-bromo-2,3-dioxobutyl)monophosphorothioate irreversibly inactivates human platelet cGMP-inhibited cAMP phosphodiesteraseSu H Hung, K S Madhusoodanan, James A Beres, et al.
Bioorganic Chemistry|April 9, 2008
A new nonhydrolyzable reactive cGMP analogue, (Rp)-guanosine-3',5'-cyclic-S-(4-bromo-2,3-dioxobutyl)monophosphorothioate, which targets the cGMP binding site of human platelet PDE3ASu H Hung, Andy H Liu, Robin A Pixley, et al.
Pageof 27

Showing results (261-270 of 265) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 265 results.
Blood|September 1, 1987
Direct evidence for the interaction of the nucleotide affinity analog 5'-p-fluorosulfonylbenzoyl adenosine with a platelet ADP receptorW R Figures, L M Scearce, P DeFeo, et al.
Archives of Biochemistry and Biophysics|April 1, 1988
Distinction between glycoprotein IIIa and the 100-kDa membrane protein (aggregin) mediating ADP-induced platelet activationR W Colman, W R Figures, Q X Wu, et al.
Transactions of the Association of American Physicians|January 1, 1986
Separation of the 100-kDa membrane protein mediating ADP-induced platelet shape change and activation from glycoprotein IIIaR W Colman, W R Figures, Q X Wu, et al.
Bioorganic Chemistry|April 17, 2002
A new nonhydrolyzable reactive cAMP analog, (Sp)-adenosine-3',5'-cyclic-S-(4-bromo-2,3-dioxobutyl)monophosphorothioate irreversibly inactivates human platelet cGMP-inhibited cAMP phosphodiesteraseSu H Hung, K S Madhusoodanan, James A Beres, et al.
Bioorganic Chemistry|April 9, 2008
A new nonhydrolyzable reactive cGMP analogue, (Rp)-guanosine-3',5'-cyclic-S-(4-bromo-2,3-dioxobutyl)monophosphorothioate, which targets the cGMP binding site of human platelet PDE3ASu H Hung, Andy H Liu, Robin A Pixley, et al.
Pageof 27